Emotionellt instabilt personlighetssyndrom - EIPS - Referenser

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 5th ed. Washington, DC2013.
  2. WHO. The ICD-10 classification of mental and behavioural disorders: Clinical descriptions and diagnostic guidelines.1992.
  3. Kaess M, Brunner R, Chanen A. Borderline personality disorder in adolescence. Pediatrics. 2014 Oct;134(4):782-93. PubMed PMID: 25246626.
  4. Fonagy P, Speranza M, Luyten P, Kaess M, Hessels C, Bohus M. ESCAP Expert Article: borderline personality disorder in adolescence: an expert research review with implications for clinical practice. European child & adolescent psychiatry. 2015 Nov;24(11):1307-20. PubMed PMID: 26271454.
  5. Miller AL, Muehlenkamp JJ, Jacobson CM. Fact or fiction: diagnosing borderline personality disorder in adolescents. Clinical psychology review. 2008 Jul;28(6):969-81. PubMed PMID: 18358579.
  6. Chanen AM. Borderline Personality Disorder in Young People: Are We There Yet? Journal of clinical psychology. 2015 Aug;71(8):778-91. PubMed PMID: 26192914.
  7. Winograd G, Cohen P, Chen H. Adolescent borderline symptoms in the community: prognosis for functioning over 20 years. Journal of child psychology and psychiatry, and allied disciplines. 2008 Sep;49(9):933-41. PubMed PMID: 18665882.
  8. Grant BF, Chou SP, Goldstein RB, Huang B, Stinson FS, Saha TD, et al. Prevalence, correlates, disability, and comorbidity of DSM-IV borderline personality disorder: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. The Journal of clinical psychiatry. 2008 Apr;69(4):533-45. PubMed PMID: 18426259. Pubmed Central PMCID: 2676679.
  9. National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder. Melbourne: National Health and Medical Research Council; 2013.
  10. NICE. Self-Harm: Longer-Term Management. Leicester (UK): National Institute for Health and Clinical Excellence: Guidance: www.nice.org.uk/guidance/CG133; 2012.
  11. Torgersen S, Kringlen E, Cramer V. The prevalence of personality disorders in a community sample. Archives of general psychiatry. 2001 Jun;58(6):590-6. PubMed PMID: 11386989.
  12. Statens beredning för medicinsk utvärdering (SBU). Erfarenheter och upplevelser av bemötande och hjälp bland personer med självskadebeteende. Stockholm: 2015.
  13. Zanarini MC, Frankenburg FR, Hennen J, Reich DB, Silk KR. Prediction of the 10-year course of borderline personality disorder. The American journal of psychiatry. 2006 May;163(5):827-32. PubMed PMID: 16648323.
  14. Ahmad A, Ramoz N, Thomas P, Jardi R, Gorwood P. "Genetics of Borderline Personality Disorder: Systematic Review and Proposal of an Integrative Model." Neuroscience and Biobehavioral Reviews, 40:6-19, 2014.
  15. Distel MA, Trull TJ, Derom CA, Thiery EW, Grimmer MA, Martin NG, et al. “Heritability of Borderline Personality Disorder Features is Similar Across Three Countries.” Psychological Medicine. 38:1219-1229, 2008
  16. Philipsen A, Limberger MF, Lieb K, Feige B, Kleindienst N, Ebner-Priemer U, et al. Attention-deficit hyperactivity disorder as a potentially aggravating factor in borderline personality disorder. The British journal of psychiatry : the journal of mental science. 2008 Feb;192(2):118-23. PubMed PMID: 18245028.
  17. Bjureberg J, Ljotsson B, Tull MT, Hedman E, Sahlin H, Lundh LG, et al. Development and Validation of a Brief Version of the Difficulties in Emotion Regulation Scale: The DERS-16. Journal of psychopathology and behavioral assessment. 2016 Jun;38(2):284-96. PubMed PMID: 27239096. Pubmed Central PMCID: 4882111.
  18. Bohus M, Limberger MF, Frank U, Sender I, Gratwohl T, Stieglitz RD. [Development of the Borderline Symptom List]. Psychotherapie, Psychosomatik, medizinische Psychologie. 2001 May;51(5):201-11. PubMed PMID: 11417358. Entwicklung der Borderline-Symptom-Liste.
  19. Gratz K. Measurement of Deliberate Self-Harm: Preliminary Data on the Deliberate Self-Harm Inventory. Journal of Psychopathology and Behavioral Assessment. 2001;23(4):253-63.
  20. Lejuez CW, Daughters SB, Nowak JA, Lynch T, Rosenthal MZ, Kosson D. Examining the inventory of interpersonal problems as a tool for conducting analogue studies of mechanisms underlying Borderline Personality Disorder. Journal of behavior therapy and experimental psychiatry. 2003 Sep-Dec;34(3-4):313-24. PubMed PMID: 14972676.
  21. Pfohl B, Blum N, St John D, McCormick B, Allen J, Black DW. Reliability and validity of the Borderline Evaluation of Severity Over Time (BEST): a self-rated scale to measure severity and change in persons with borderline personality disorder. Journal of personality disorders. 2009 Jun;23(3):281-93. PubMed PMID: 19538082. Pubmed Central PMCID: 3608461.
  22. Allen A, Links PS. Aggression in borderline personality disorder: evidence for increased risk and clinical predictors. Current psychiatry reports. 2012 Feb;14(1):62-9. PubMed PMID: 22033830.
  23. Newhill CE, Eack SM, Mulvey EP. Violent behavior in borderline personality. Journal of personality disorders. 2009 Dec;23(6):541-54. PubMed PMID: 20001173.
  24. NICE. Borderline personality disorder: recognition and management. National Institute for Health and Clinical Excellence. Guideslines N, editor: Nice.org.uk/guidance/cg78; 2009, s 20-22.
  25. Svenska Psykiatriska Föreningen. PERSONLIGHETSSTÖRNINGAR – kliniska riktlinjer för utredning och behandling. Stockholm: Gothia förlag; 2009.
  26. Brent DA, McMakin DL, Kennard BD, Goldstein TR, Mayes TL, Douaihy AB. Protecting adolescents from self-harm: a critical review of intervention studies. Journal of the American Academy of Child and Adolescent Psychiatry. 2013 Dec;52(12):1260-71. PubMed PMID: 24290459. Pubmed Central PMCID: 3873716.
  27. McMain SF, Links PS, Gnam WH, Guimond T, Cardish RJ, Korman L, et al. A randomized trial of dialectical behavior therapy versus general psychiatric management for borderline personality disorder. The American journal of psychiatry. 2009 Dec;166(12):1365-74. PubMed PMID: 19755574.
  28. Bateman A, Fonagy P. Randomized controlled trial of outpatient mentalization-based treatment versus structured clinical management for borderline personality disorder. The American journal of psychiatry. 2009 Dec;166(12):1355-64. PubMed PMID: 19833787.
  29. Lundh L. Behandlingseffekter på självskadebeteende: Vad visar forskningen? Lund: Nationella Självskadeprojektet; 2013.
  30. NICE. Borderline Personality Disorder, Treatment and Management. Guidelines NC, editor 2009.
  31. Fruzzetti AE, Shenk C, Hoffman PD. Family interaction and the development of borderline personality disorder: a transactional model. Development and psychopathology. 2005 Fall;17(4):1007-30. PubMed PMID: 16613428.
  32. Glenn CR, Franklin JC, Nock MK. Evidence-based psychosocial treatments for self-injurious thoughts and behaviors in youth. Journal of clinical child and adolescent psychology : the official journal for the Society of Clinical Child and Adolescent Psychology, American Psychological Association, Division 53. 2015;44(1):1-29. PubMed PMID: 25256034. Pubmed Central PMCID: 4557625.
  33. MacPherson HA, Cheavens JS, Fristad MA. Dialectical behavior therapy for adolescents: theory, treatment adaptations, and empirical outcomes. Clinical child and family psychology review. 2013 Mar;16(1):59-80. PubMed PMID: 23224757.
  34. Mehlum L, Tormoen AJ, Ramberg M, Haga E, Diep LM, Laberg S, et al. Dialectical behavior therapy for adolescents with repeated suicidal and self-harming behavior: a randomized trial. Journal of the American Academy of Child and Adolescent Psychiatry. 2014 Oct;53(10):1082-91. PubMed PMID: 25245352.
  35. Sharp C, Fonagy P. Practitioner Review: Borderline personality disorder in adolescence--recent conceptualization, intervention, and implications for clinical practice. Journal of child psychology and psychiatry, and allied disciplines. 2015 Dec;56(12):1266-88. PubMed PMID: 26251037.
  36. Nationella Självskadeprojektet, Centrum för Psykiatriforskning. Stockholm. http://nationellasjalvskadeprojektet.se/rekommendationer-for-vard/rekommendation-6-behandling/
  37. National Health and Medical Research Council. Clinical Practice Guideline for the Management of Borderline Personality Disorder. Melborne: National Health and Medical Research Council; 2013, s 63.
Publicerad: 2016/12/15 Senast uppdaterad: